Your session is about to expire
← Back to Search
Deep TMS for Stimulant Use Disorder (SUDdTMS Trial)
SUDdTMS Trial Summary
This trialwill test a new treatment for people struggling with substance use disorder: a magnetic coil placed on the head.
SUDdTMS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSUDdTMS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SUDdTMS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have severe psychiatric conditions like schizophrenia or bipolar disorder.I do not have any severe or unstable illnesses like heart, kidney, liver, or neurological conditions.You want to stop taking drugs that stimulate your body.You have a serious addiction to drugs or alcohol (excluding nicotine).You have a medical device implanted in your body like a pacemaker or a device in your head that cannot be safely removed.You are pregnant or currently breastfeeding.I take more than 2 mg of lorazepam daily or any anticonvulsant.I am willing and able to agree to treatment.I can speak and read either French or English.My medication for cravings or mental health has been the same for the last 4 weeks.
- Group 1: H7-Coil Deep TMS Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I eligible to enlist in this clinical trial?
"This clinical trial is recruiting 30 people aged 21 to 65 with cocaine use disorders (SUD) based on DSM-5 criteria, recent stimulants intake in the two weeks preceding recruitment, and a desire to cease usage. Furthermore, candidates must display competency for consenting to treatment and pass an adult safety screening questionnaire; they must also be fluent in either English or French."
Does the trial admit participants who are of legal age?
"This medical trial is designed for participants between the ages of 21 to 65. Those under 18 can find 248 studies, while those over 65 have 627 options available."
What are the projected outcomes of this experiment?
"This trial is evaluating the feasibility of treatment by monitoring participant retention across a 10-day timeframe. Secondary results will be tracked with urine drug screening, Stimulants Selective Severity Assessment scores (ranging from 0–126), and Patient Health Questionnaire (PHQ-9) changes."
Are there any remaining openings for people to participate in this investigation?
"According to the information found on clinicaltrials.gov, recruitment for this medical experiment has commenced and is ongoing. The trial was initially announced on November 2nd 2022 with the latest update being posted 9 days later."
How many persons are actively participating in this experiment?
"Absolutely. Details on clinicaltrials.gov make mention that this experiment is presently seeking participants, with the first posting being made on November 2nd 2022 and last updated 9 days later. The trial will accept 30 patients from a single medical facility."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger